Photo of Katrina Armstrong,  MD

Katrina Armstrong, MD

Harvard Medical School

Harvard Medical School
Phone: (617) 726-8447
Fax: (617) 724-7441


karmstrong6@partners.org

Katrina Armstrong, MD

Harvard Medical School

EDUCATIONAL TITLES

  • Jackson Professor, Medicine, Harvard Medical School

DF/HCC PROGRAM AFFILIATION

Research Abstract

Dr. Armstrong investigates the causes of disparities in cancer prevention and outcomes particularly focusing on the use of new technology to improve screening, prevention and treatment.

Publications

Powered by Harvard Catalyst
  • Dean LT, Moss SL, McCarthy AM, Armstrong K. Healthcare System Distrust, Physician Trust, and Patient Discordance with Adjuvant Breast Cancer Treatment Recommendations. Cancer Epidemiol Biomarkers Prev 2017. PubMed
  • Jones T, McCarthy AM, Kim Y, Armstrong K. Predictors of BRCA1/2 genetic testing among Black women with breast cancer: a population-based study. Cancer Med 2017. PubMed
  • Armstrong K. Equity in Precision Medicine: Is It Within Our Reach? J Natl Compr Canc Netw 2017; 15:421-423. PubMed
  • Pollack CE, Armstrong K, Grande D. A View from the Front Line - Physicians' Perspectives on ACA Repeal. N Engl J Med 2017; 376:e8. PubMed
  • Armstrong K, Anderson ME, Carethers JM, Loscalzo J, Parmacek MS, Wachter RM, Zeidel ML. International Exchange and American Medicine. N Engl J Med 2017. PubMed
  • Kim Y, McCarthy AM, Bristol M, Armstrong K. Disparities in contralateral prophylactic mastectomy use among women with early-stage breast cancer. NPJ Breast Cancer 2017; 3:2. PubMed
  • McCarthy AM, Keller BM, Pantalone LM, Hsieh MK, Synnestvedt M, Conant EF, Armstrong K, Kontos D. Racial Differences in Quantitative Measures of Area and Volumetric Breast Density. Journal of the National Cancer Institute 2016. PubMed
  • McCarthy AM, Bristol M, Domchek SM, Groeneveld PW, Kim Y, Motanya UN, Shea JA, Armstrong K. Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer. J Clin Oncol 2016. PubMed
  • Morland TB, Synnestvedt M, Honeywell S, Yang F, Armstrong K, Guerra C. Effect of a Financial Incentive for Colorectal Cancer Screening Adherence on the Appropriateness of Colonoscopy Orders. 2016. PubMed
  • Seitz HH, Gibson L, Skubisz C, Forquer H, Mello S, Schapira MM, Armstrong K, Cappella JN. Effects of a risk-based online mammography intervention on accuracy of perceived risk and mammography intentions. Patient Educ Couns 2016. PubMed
  • Armstrong K, Kim JJ, Halm EA, Ballard RM, Schnall MD. Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs. Cancer 2016; 122:1338-42. PubMed
  • McCarthy AM, Kim JJ, Beaber EF, Zheng Y, Burnett-Hartman A, Chubak J, Ghai NR, McLerran D, Breen N, Conant EF, Geller BM, Green BB, Klabunde CN, Inrig S, Skinner CS, Quinn VP, Haas JS, Schnall M, Rutter CM, Barlow WE, Corley DA, Armstrong K, Doubeni CA, . Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity. Am J Prev Med 2016. PubMed
  • Conant EF, Beaber EF, Sprague BL, Herschorn SD, Weaver DL, Onega T, Tosteson AN, McCarthy AM, Poplack SP, Haas JS, Armstrong K, Schnall MD, Barlow WE. Breast cancer screening using tomosynthesis in combination with digital mammography compared to digital mammography alone: a cohort study within the PROSPR consortium. Breast Cancer Res Treat 2016; 156:109-16. PubMed
  • Kim JJ, Tosteson AN, Zauber AG, Sprague BL, Stout NK, Alagoz O, Trentham-Dietz A, Armstrong K, Pruitt SL, Rutter CM, . Cancer Models and Real-world Data: Better Together. Journal of the National Cancer Institute 2015. PubMed
  • Vachani A, Wong YN, Israelite J, Mitra N, Hin S, Yang L, Smith-McLallen A, Armstrong K, Groeneveld PW, Epstein AJ. Validation of Molecular Pathology Codes for the Identification of Mutational Testing in Lung and Colon Cancer. Med Care 2016. PubMed
  • Pollack CE, Ross ME, Armstrong K, Branas CC, Rhodes KV, Bekelman JE, Wentz A, Stillson C, Radhakrishnan A, Oyeniran E, Grande D. Using a Mystery-Caller Approach to Examine Access to Prostate Cancer Care in Philadelphia. PLoS ONE 2016; 11:e0164411. PubMed
  • Li P, Wong YN, Armstrong K, Haas N, Subedi P, Davis-Cerone M, Doshi JA. Survival among patients with advanced renal cell carcinoma in the pretargeted versus targeted therapy eras. Cancer Med 2015. PubMed
  • Epstein AJ, Wong YN, Mitra N, Vachani A, Hin S, Yang L, Smith-McLallen A, Armstrong K, Groeneveld PW. Adjuvant Chemotherapy Use and Health Care Costs After Introduction of Genomic Testing in Breast Cancer. J Clin Oncol 2015. PubMed
  • Freer PE, Slanetz PJ, Haas JS, Tung NM, Hughes KS, Armstrong K, Semine AA, Troyan SL, Birdwell RL. Breast cancer screening in the era of density notification legislation: summary of 2014 Massachusetts experience and suggestion of an evidence-based management algorithm by multi-disciplinary expert panel. Breast Cancer Res Treat 2015; 153:455-64. PubMed
  • Dean LT, Subramanian SV, Williams DR, Armstrong K, Zubrinsky Charles C, Kawachi I. Getting Black Men to Undergo Prostate Cancer Screening: The Role of Social Capital. Am J Mens Health 2015. PubMed
  • McCarthy AM, Yamartino P, Yang J, Bristol M, Conant EF, Armstrong K. Racial differences in false-positive mammogram rates: results from the ACRIN Digital Mammographic Imaging Screening Trial (DMIST). Med Care 2015; 53:673-8. PubMed
  • Zafar HM, Yang J, Armstrong K, Groeneveld P. Cost Differences After Initial CT Colonography Versus Optical Colonoscopy in the Elderly. Acad Radiol 2015; 22:807-13. PubMed
  • McCarthy AM, Yang J, Armstrong K. Increasing disparities in breast cancer mortality from 1979 to 2010 for US black women aged 20 to 49 years. Am J Public Health 2015; 105 Suppl 3:S446-8. PubMed
  • Wasfy JH, Armstrong K, Milford CE, Sundt TM. Doctors should share their uncertainty with patients and make decisions together. Int. J. Cardiol. 2015; 187:109-10. PubMed
  • Veenstra CM, Epstein AJ, Liao K, Griggs JJ, Pollack CE, Armstrong K. Hospital academic status and value of care for nonmetastatic colon cancer. J Oncol Pract 2015; 11:e304-12. PubMed
  • Bekelman JE, Mitra N, Handorf EA, Uzzo RG, Hahn SA, Polsky D, Armstrong K. Effectiveness of androgen-deprivation therapy and radiotherapy for older men with locally advanced prostate cancer. J Clin Oncol 2015; 33:716-22. PubMed
  • Wasfy JH, Armstrong K, Milford CE, Sundt TM. Bicuspid aortic disease and decision making under uncertainty - The limitations of clinical guidelines. Int. J. Cardiol. 2015; 181:169-71. PubMed
  • Glanz K, Volpicelli K, Jepson C, Ming ME, Schuchter LM, Armstrong K. Effects of tailored risk communications for skin cancer prevention and detection: the PennSCAPE randomized trial. Cancer Epidemiol Biomarkers Prev 2015; 24:415-21. PubMed
  • McCarthy AM, Keller B, Kontos D, Boghossian L, McGuire E, Bristol M, Chen J, Domchek S, Armstrong K. The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms. Breast Cancer Res 2015; 17:1. PubMed
  • Keller BM, McCarthy AM, Chen J, Armstrong K, Conant EF, Domchek SM, Kontos D. Associations between breast density and a panel of single nucleotide polymorphisms linked to breast cancer risk: a cohort study with digital mammography. BMC Cancer 2015; 15:143. PubMed
  • Katrina Armstrong, MD, Elizabeth A. Handorf, MS, Jinbo Chen, PhD, and Mirar N. Bristol. Breast Cancer Risk Prediction and Mammography Biopsy 2014.
Hide